Objective: To study the predictive value of 6 ultrasonographic (USG) parameters for early detection of children at risk of recurrent obstruction. Patients and Methods: A prospective nonrandomized study included all patients who underwent pyeloplasty between 2010 and 2012. All of the patients had completed at least 6 months of follow-up and preoperative and postoperative USG imaging data were available. The primary outcome was the correlation between USG and diuretic scintigraphic parameters. The secondary outcome was the predictive ability of the pelvicalyceal system parameters, measured by USG, of parenchymal growth after surgery. Results: Sixty-eight patients were evaluated. The mean age was 3.6 years (range 0.1-12). The mean (± standard deviation) differential renal function improved from 37.4 ± 11 ml/min to 37.7 ± 14 ml/min, which was a difference of no statistical significance. On the other hand, the mean (± SD) half-time (T1/2) significantly improved. After constructing a linear regression model of the 4 USG parameters and the parenchymal growth, the model explained 57.2% of the variance in parenchymal growth after pyeloplasty. The calyx-to-parenchyma ratio change was the largest unique contribution for explaining the variance in parenchymal growth, followed by anteroposterior diameter and calyceal dilatation. Conclusion: We proved that calyx-to-parenchyma ratio, anteroposterior diameter and calyceal dilatation are independent predictors of early success after pyeloplasty.

Keywords:
Pyeloplasty, Differential renal function, Cortical thickness, Ultrasound
1.
Imaji R, Dewan PA: Calyx-to-parenchyma ratio in pelvi-ureteric junction obstruction. BJU Int 2002;89:73-76.
2.
Capello SA, Kogan BA, Giorgi LJ, et al: Prenatal ultrasound has led to earlier detection and repair of ureteropelvic junction obstruction. J Urol 2005;174:1425-1429.
3.
Seixas-Mikelus SA, Jenkins LC, Williot P, et al: Pediatric pyeloplasty: comparison of literature meta-analysis of laparoscopic and open techniques with open surgery at a single institution. J Urol 2009;182:2428-2431.
4.
Romao R, Farhat WA, Pippi Salle J, et al: Early postoperative ultrasound after open pyeloplasty in children with prenatal hydronephrosis helps identify low risk of recurrent obstruction. J Urol 2012;188:2347-2353.
5.
Lee RS, Cendron M, Kinnamon DD, et al: Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-analysis. Pediatrics 2006;118:586-590.
6.
Palmer LS, Maizels M, Cartwright PC, et al: Surgery versus observation for managing obstructive grade 3 to 4 unilateral hydronephrosis: a report from the Society for Fetal Urology. J Urol 1998;159:222-226.
7.
Babu R, Sai V: Pelvis/cortex ratio: a sonographic marker of pelviureteric junction obstruction in children. Indian J Urol 2010;26:494-498.
8.
Ansari MS: Pelvis/cortex ratio in pelviureteric junction obstruction. Indian J Urol 2010;26:472-476.
9.
Helmy TE, Sarhan OM, Sharaf DE, et al: Critical analysis of outcome after open dismembered pyeloplasty in ectopic pelvic kidneys in a pediatric cohort. Urology 2012;80:1357-1360.
10.
Gordon I, Piepsz A, Sixt R: Guidelines for standard and diuretic renogram in children. Eur J Nucl Med Mol Imaging 2011;38:1175-1188.
11.
Sarhan O, Helmy T, Abou-El Ghar M, et al: Long-term functional and morphological outcome after pyeloplasty for huge renal pelvis. BJU Int 2011;107:829-831.
12.
Hafez AT, McLorie G, Bagli D, Khoury A: Analysis of trends on serial ultrasound for high grade neonatal hydronephrosis. J Urol 2002;168:1518-1521.
13.
Chertin B, Pollack A, Koulikov D, et al: Does renal function remain stable after puberty in children with prenatal hydronephrosis and improved renal function after pyeloplasty? J Urol 2009;182:1845-1848.
14.
Van den Hoek J, de Jong A, Scheepe J, et al: Prolonged follow-up after paediatric pyeloplasty: are repeat scans necessary? BJU Int 2007;100:1150-1152.
15.
Almodhen F, Jednak R, Capolicchio JP, et al: Is routine renography required after pyeloplasty? J Urol 2010 184:1128-1131.
16.
Cost NG, Prieto JC, Wilcox DT: Screening ultrasound in follow-up after pediatric pyeloplasty. Urology 2010;76:175-179.
17.
Onen A: An alternative grading system to refine the criteria for severity of hydronephrosis and optimal treatment guidelines in neonates with primary UPJ-type hydronephrosis. J Pediatr Urol 2007;3:200-205.
18.
Kis E, Verebély T, Kövi R, Máttyus I: The role of ultrasound in the follow-up of postoperative changes after pyeloplasty. Pediatr Radiol 1998;28:247-249.
19.
Chipde S, Lal H, Gambhir S, et al: Factors predicting improvement of renal function after pyeloplasty in pediatric patients: a prospective study. J Urol 2012;188:262-265.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.